- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CD19-positive in Brazil
Total 151 results
-
Eunice Kennedy Shriver National Institute of Child...CompletedPregnant HIV Positive WomenArgentina, Brazil, Peru
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulCompleted
-
Hospital de Clinicas de Porto AlegreCompleted
-
Johns Hopkins UniversityCairo University; United States Agency for International Development (USAID); World Health Organization and other collaboratorsCompletedStreptococcal Infections | PharyngitisEgypt, Croatia, Brazil
-
National Institute of Allergy and Infectious Diseases...Completed
-
Fundação de Medicina Tropical Dr. Heitor Vieira...UnknownHIV/AIDS | Tuberculosis, PulmonaryBrazil
-
ANRS, Emerging Infectious DiseasesMerck Sharp & Dohme LLC; Ministry of Health, BrazilCompletedTuberculosis | HIV-1 InfectionFrance, Vietnam, Brazil, Côte D'Ivoire, Mozambique
-
Hospital Israelita Albert EinsteinTerminatedChronic Myelomonocytic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Acute Lymphoid Leukemia | Myeloproliferative DiseaseBrazil
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingTuberculosis | Rifampicin Resistant TuberculosisBrazil, India, South Africa, Tanzania, Thailand
-
Novartis PharmaceuticalsActive, not recruitingALK Positive MalignanciesChina, United States, Italy, Taiwan, Australia, Belgium, Germany, Spain, Czechia, Japan, Russian Federation, Korea, Republic of, Hong Kong, France, Lebanon, Malaysia, Brazil, Poland, Bulgaria, Colombia, Singapore
-
ANRS, Emerging Infectious DiseasesMerck Sharp & Dohme LLC; Gilead SciencesCompletedHIV Infections | TuberculosisFrance, Brazil
-
Alexion PharmaceuticalsTerminatedAntiphospholipid (aPL)-PositiveUnited States, Italy, Brazil, France, Japan, United Kingdom
-
ANRS, Emerging Infectious DiseasesRecruitingTnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis (TIMPANI)Tuberculous Meningitis | HIV I InfectionMozambique, Brazil, Zambia
-
Janssen Infectious Diseases BVBACompletedTuberculosisSouth Africa, Peru, Latvia, Philippines, Russian Federation, Thailand, Brazil, India
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)TerminatedHIV Infection | TuberculosisPeru, Brazil, South Africa, Haiti, Kenya
-
GlaxoSmithKlineCompletedInfections, StreptococcalRomania
-
McGill UniversityCanadian Institutes of Health Research (CIHR)CompletedLatent Tuberculosis InfectionCanada, Australia, Benin, Brazil, Ghana, Guinea, Indonesia
-
University Medical Center GroningenUnknownTuberculosis, Multidrug-ResistantSweden, United Kingdom, Australia, Belarus, Brazil, Greece, Italy, Latvia, Mexico, Netherlands, Portugal, South Africa, Tanzania
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID); National Institute...CompletedHIV Infections | TuberculosisPeru, South Africa, Botswana, Brazil, India, Malawi, Zimbabwe
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Hospital de Clinicas de Porto AlegreRecruitingAcute Respiratory Distress Syndrome | Prone PositionBrazil
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLCCompletedIncidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin AmericaHIV Infection | Malignant Neoplasm | Recurrent Malignant Neoplasm | Human Immunodeficiency Virus 1 PositiveMexico, Argentina, Brazil
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; University of Sao Paulo and other collaboratorsActive, not recruitingHPV Infection | HIV-1-infection | HPV Positive Oropharyngeal Squamous Cell CarcinomaBrazil, Mexico, Puerto Rico
-
McGill UniversityCanadian Institutes of Health Research (CIHR)CompletedLatent Tuberculosis InfectionCanada, Australia, Benin, Brazil, Ghana, Indonesia, Guinea, Korea, Republic of, Saudi Arabia
-
Novartis PharmaceuticalsCompleted
-
Centers for Disease Control and PreventionUS Department of Veterans AffairsCompletedTuberculosisUnited States, Canada, Brazil, Spain
-
Centers for Disease Control and PreventionBayer; Global Alliance for TB Drug DevelopmentCompletedTuberculosisUganda, United States, South Africa, Canada, Brazil, Spain
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV InfectionPeru, Malawi, Uganda, South Africa, India, Haiti, Zambia, Zimbabwe, Brazil, Kenya
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV Infections | TuberculosisUnited States, South Africa, Malawi, Brazil, Kenya, Thailand, Botswana
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV Infection | TuberculosisUnited States, Peru, Kenya, Malawi, Uganda, Brazil, South Africa, Zimbabwe, India, Thailand, Botswana, Haiti, Zambia
-
Novartis PharmaceuticalsWithdrawnChronic Myeloid Leukemia (CML)Brazil
-
Hoffmann-La RocheRecruitingALK Fusion-positive Solid or CNS TumorsUnited States, Korea, Republic of, China, Spain, Canada, Australia, United Kingdom, Denmark, France, Italy, Germany, Brazil
-
Centers for Disease Control and PreventionUS Department of Veterans AffairsCompletedTuberculosisUnited States, Canada, Spain, Brazil
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
ISA PharmaceuticalsRegeneron PharmaceuticalsActive, not recruitingSquamous Cell Carcinoma of the Oropharynx | HPV16 PositiveNetherlands, United States, United Kingdom, France, Belgium, Czechia, Spain, Italy, Germany, Brazil, Hungary, Mexico, Poland
-
National Institute of Allergy and Infectious Diseases...TB AllianceNot yet recruitingPulmonary TuberculosisBotswana, Brazil, Haiti, India, Kenya, Malawi, Mexico, Peru, Philippines, South Africa, Thailand, Uganda, Zimbabwe
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsUnited States, Australia, Belgium, Brazil, Canada, Colombia, France, Germany, Mexico, Sweden
-
Gruppo Italiano Malattie EMatologiche dell'AdultoUnknownChronic Myeloid LeukemiaGermany, Italy, Austria, Iraq, United States, Brazil, China, Malaysia, Netherlands
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingTuberculosis, MDRHaiti, Tanzania, Thailand, Botswana, Brazil, India, Kenya, Peru, Philippines, South Africa, Uganda, Zimbabwe, Vietnam
-
Centers for Disease Control and PreventionAIDS Clinical Trials GroupCompletedTuberculosisUnited States, Brazil, China, Haiti, India, Kenya, Malawi, Peru, South Africa, Thailand, Uganda, Vietnam, Zimbabwe
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Leukemia, Lymphoblastic, Acute, Philadelphia-positiveNetherlands, United States, Italy, Argentina, Austria, Brazil, Canada, Germany, Peru, United Kingdom, France, Korea, Republic of, Sweden, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzerland
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | TuberculosisBrazil, United States, Kenya, Peru, South Africa, Thailand, Botswana, Haiti, Malawi, Zimbabwe
-
ActelionCompletedClostridium Difficile InfectionUnited States, Australia, Brazil, Canada, France, Germany, Italy, Netherlands, Peru, Poland, Romania, Spain
-
PfizerCompletedChronic Myeloid LeukemiaUnited States, Spain, Australia, Canada, Hong Kong, Singapore, United Kingdom, Germany, Netherlands, Chile, India, South Africa, Sweden, Peru, Argentina, Italy, Austria, Colombia, Brazil, China, Finland, Hungary, Korea, Republic of, M... and more
-
BioMérieuxCompletedActive Tuberculosis | Latent Tuberculosis Infection | Non-Tuberculous Mycobacterial (NTM) PneumoniaUnited States, France, United Kingdom, India, Brazil, Georgia, Italy, Mexico, South Africa
-
Poitiers University HospitalUniversity Medical Center Groningen; Imperial College London; University of Liege and other collaboratorsRecruitingChronic Myeloid LeukemiaDenmark, China, Germany, Australia, Belgium, Brazil, Chile, Croatia, Czechia, France, Greece, Japan, Lebanon, Poland, Spain, Turkey, Austria, Belarus, Netherlands, Slovakia
-
Janssen Infectious Diseases BVBAWithdrawnMulti-drug Resistant TuberculosisChina, Ukraine, Taiwan, Korea, Republic of, Peru, Brazil, Estonia, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey, Georgia, Mexico, Cambodia, Ethiopia
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Spain, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Puerto Rico, Singapore, South Africa, Taiwan, United Kingdom, Australia, France, Philippines, Sweden, Thailand, Russian Federation, China, Poland, Finland, Isra... and more